CASI Pharmaceuticals
CASI
#10628
Rank
NZ$7.13 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-88.79%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.63. In 2024 the company made an earnings per share (EPS) of NZ-$4.28 a decrease over its 2023 EPS that were of NZ-$3.38.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.658.59%
2024NZ-$4.2826.73%
2023NZ-$3.38-32.89%
2022NZ-$5.0411.9%
2021NZ-$4.50-38.44%
2020NZ-$7.31-8.96%
2019NZ-$8.0350%
2018NZ-$5.3577.78%
2017NZ-$3.015.88%
2016NZ-$2.84-22.73%
2015NZ-$3.68-76.09%
2014NZ-$15.39318.18%
2013NZ-$3.68-71.79%
2012NZ-$13.0565.96%
2011NZ-$7.86-50%
2010NZ-$15.73-18.97%
2009NZ-$19.41-63.64%
2008NZ-$53.373.57%
2007NZ-$51.53-60.56%
2006NZ-$130.6797.22%
2005NZ-$66.25-2.7%
2004NZ-$68.10-45.59%
2003NZ-$125.15-61.8%
2002NZ-$327.59-25.52%
2001NZ-$439.86-21.38%
2000NZ-$559.4913.86%
1999NZ-$491.39149.53%
1998NZ-$196.9298.15%
1997NZ-$99.3810.2%
1996NZ-$90.18